HPHA — Heidelberg Pharma AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Heidelberg Pharma AG, fiscal year end - November 30th, EUR millions except per share, conversion factor applied.

	2020 November 30th	2021 November 30th	2022 November 30th	2023 November 30th	2024 November 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4.98	6.14	81.3	43.4	29.4
Net Total Accounts Receivable
Net Total Receivables	1.51	1.45	1.45	2.32	5.95
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7.52	9.01	87.9	56.6	47.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.11	3.67	3.72	3.85	3.49
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	19.6	21.7	101	70.4	60.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.63	14.9	27.9	19.8	8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.73	15	33.9	21	29.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	12.9	6.7	66.6	49.3	30.9
Total Liabilities & Shareholders' Equity	19.6	21.7	101	70.4	60.7
Total Common Shares Outstanding